GSK-204486

Study Sponsor: GSK

Study Title

Cross-vaccination study of GSK Biologicals’ Lyophilized formulation of the Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A) in subjects who previously received placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) studies

Medicine or Vaccine (generic name)

Herpes Zoster subunit (HZ/su) vaccine

Sponsor Identification Number

204486

Trial Registry Identification Number(#'s)

NCT02690207 2015-000965-30

Medical Condition

Herpes Zoster

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204486

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02690207

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2015-000965-30

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This is a nested study of 110390/113077.

Date Added to this Site

January 2021